SC
SBBP

Steven Cohen’s Strongbridge Biopharma plc. SBBP Stock Holding History

Steven Cohen’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-653,000
Closed -$1.36M – 1195
2019
Q4 		$1.36M Buy
653,000
+178,000
+37% +$341K 0.01% 673
2019
Q3 		$1.14M Buy
+475,000
New +$1.28M 0.01% 671

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Steven Cohen's SBBP Position: Q1 2020 in Review

Steven Cohen sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2020, closing a stake of 653,000 shares — an estimated $1.36M sold.

Steven Cohen first reported a position in SBBP in Q3 2019 and held it in 2 quarters. The position peaked at $1.36M in Q4 2019. 60 funds tracked by Wall St. Rank hold SBBP as of Q1 2020.

  • Steven Cohen reported no remaining Strongbridge Biopharma plc. position as of Q1 2020 after selling out during the quarter.
  • Steven Cohen sold 653,000 Strongbridge Biopharma plc. shares in Q1 2020, an estimated $1.36M.
  • Steven Cohen first reported a position in Strongbridge Biopharma plc. in Q3 2019 and held it in 2 quarters.
  • Steven Cohen's Strongbridge Biopharma plc. position peaked at $1.36M in Q4 2019.
  • 60 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2020.

Based on Point72 Asset Management's 13F filing for Q1 2020, filed 15 May 2020.